A study on vunakizumab for rheumatic diseases
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at how well vunakizumab works for people with certain inflammatory rheumatic conditions, like ankylosing spondylitis or psoriatic arthritis. It tracks symptoms, how the medicine is used, and any side effects over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rheumatic autoimmune condition (like ankylosing spondylitis, psoriatic arthritis, or similar).
- You are currently using or plan to start vunakizumab treatment.
- You can come to follow-up visits as advised by your doctor.
- You understand and sign a consent form to join the study.
- Your doctor does not think you have any reason that would make it unsafe or hard for you to complete the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new medications, vunakizumab and ivarmacitinib, for people with active Takayasu's arteritis (TAK) that is not fully controlled by standard treatments. The goal is to see if these drugs are safe and effective for reducing disease activity.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study tests a new medication called vilamakitug for people with active axial spondyloarthritis. It aims to see if the drug can reduce pain and inflammation better than a placebo (a dummy treatment).
This trial tests a drug called bimekizumab in children and teens with specific types of juvenile arthritis (enthesitis-related arthritis or psoriatic arthritis). It aims to see how the drug works in the body and if it's safe. This may help those who haven't gotten enough relief from standard anti-inflammatory medicines.
This trial tests a new biologic drug called Vunakizumab for adults with spondyloarthritis (a type of arthritis affecting the spine). It aims to see if the drug can help control symptoms and inflammation.
This trial tests a new drug called Vunakizumab for people with mild to moderate lupus that affects the skin or joints. It aims to see if adding this drug to your current treatment can help control symptoms better.
Hear when a new Psoriatic Arthritis (PsA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.